Herbas VPB

Print
EN | LT
Supplementary protection
LT - C-arilgliukozido SGLT2 inhibitoriai ir būdas
EN - C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD
SPC
(11) Number of the document C 1506211
(68) Number of the document 1506211
(21) Application number for Supplementary Protection Certificate PA 2014 026
(22) Date of filing the application 2014-07-09
(41) Date of publication of the application 2014-08-25
Date of publication of SPC 2015-06-25
(24) Date of coming into effect of SPC 2023-05-16
Applicant
(71) AstraZeneca AB, ., SE-151 85, Södertälje, SE
Grantee
(73) AstraZeneca AB, ., SE-151 85, Södertälje, SE
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/13/900, 2014-01-16
Calculated date of expiry of the SPC
(94) 2028-05-16
Name of the product protected by the basic patent
(95) Dapagliflozinum + metforminum
Last renewal fee
Payment date Validity (years) Amount
2025-04-23 3 347.00 EUR
Next renewal fee
2026-05-16
Legal status
SPC granted
Last update date 2025-04-24